These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9717683)

  • 21. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin, interleukin-6, C-reactive protein and leukocyte counts in infants with bronchiolitis.
    Resch B; Gusenleitner W; Müller W
    Pediatr Infect Dis J; 2003 May; 22(5):475-6. PubMed ID: 12792393
    [No Abstract]   [Full Text] [Related]  

  • 23. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department.
    Riedel S; Melendez JH; An AT; Rosenbaum JE; Zenilman JM
    Am J Clin Pathol; 2011 Feb; 135(2):182-9. PubMed ID: 21228358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procalcitonin in children with suspected novel influenza A (H1N1) infection.
    Limper M; Smit PM; Bongers KM; van Zanten AP; Smits PH; Brandjes DP; Mulder JW; von Rosenstiel IA; van Gorp EC
    J Infect; 2010 Oct; 61(4):351-3. PubMed ID: 20638412
    [No Abstract]   [Full Text] [Related]  

  • 25. Procalcitonin to detect invasive bacterial infection in non-toxic-appearing infants with fever without apparent source in the emergency department.
    Luaces-Cubells C; Mintegi S; García-García JJ; Astobiza E; Garrido-Romero R; Velasco-Rodríguez J; Benito J
    Pediatr Infect Dis J; 2012 Jun; 31(6):645-7. PubMed ID: 22333704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin--a marker of invasive fungal infection?
    Dornbusch HJ; Strenger V; Kerbl R; Lackner H; Schwinger W; Sovinz P; Urban C
    Support Care Cancer; 2005 May; 13(5):343-6. PubMed ID: 15657690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of sepsis due to bacterial infection--procalcitonin].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():202-8. PubMed ID: 21761773
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathobiochemistry and clinical use of procalcitonin.
    Struck J
    Clin Chim Acta; 2003 Feb; 328(1-2):199; author reply 201. PubMed ID: 12559620
    [No Abstract]   [Full Text] [Related]  

  • 29. A light initiated chemiluminescent immunoassay for procalcitonin.
    Tian Y; Lv J; Wang J; Qin Y; Liu J; Zhao W
    Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):817-9. PubMed ID: 25129476
    [No Abstract]   [Full Text] [Related]  

  • 30. [Procalcitonin as a predictor of bacteremia in pediatric patients with malignancies and febrile neutropenia].
    Aliyev DA; Vezirova ZSh; Geyusheva TF
    Klin Khir; 2015 Feb; (2):70-2. PubMed ID: 25985703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical application of sepsis biomarkers.
    Sankar V; Webster NR
    J Anesth; 2013 Apr; 27(2):269-83. PubMed ID: 23108494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin as a postmortem sepsis marker. A comparison of the validity of results obtained from blood serum, aqueous humour and cerebrospinal fluid.
    Schmidt S; Windgassen M; Nofer JR; Pfeiffer H; Ribbecke S; Schmeling A
    Int J Legal Med; 2015 Jan; 129(1):117-23. PubMed ID: 25119683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of Procalcitonin Measurement for the Detection of Sepsis].
    Toh H; Harada S; Kakudou T; Era F; Tokushige C; Yoshimura H; Kawashima H; Ohkubo K; Ishikura H; Matsunaga A
    Rinsho Byori; 2014 Oct; 62(10):931-6. PubMed ID: 27526537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
    Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
    Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Procalcitonin--a new marker and mediator of the systemic inflammatory reaction to infection in the host ].
    Mikić D
    Vojnosanit Pregl; 2003; 60(5):597-604. PubMed ID: 14608839
    [No Abstract]   [Full Text] [Related]  

  • 36. Procalcitonin in bacterial infections--hype, hope, more or less?
    Christ-Crain M; Müller B
    Swiss Med Wkly; 2005 Aug; 135(31-32):451-60. PubMed ID: 16208582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of procalcitonin to occult bacteraemia detection in children.
    Guen CG; Delmas C; Launay E; Caillon J; Loubersac V; Picherot G; Roze JC
    Scand J Infect Dis; 2007; 39(2):157-9. PubMed ID: 17366034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of procalcitonin. Valuable for reducing ineffective antibiotic use is debatable].
    Damoiseaux RA
    Ned Tijdschr Geneeskd; 2009 Feb; 153(7):268-9. PubMed ID: 19291938
    [No Abstract]   [Full Text] [Related]  

  • 39. Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al.
    Moosig F; Reinhold-Keller E; Csernok E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):566-7; author reply 568. PubMed ID: 9506590
    [No Abstract]   [Full Text] [Related]  

  • 40. Laboratory detection of sepsis: biomarkers and molecular approaches.
    Riedel S; Carroll KC
    Clin Lab Med; 2013 Sep; 33(3):413-37. PubMed ID: 23931833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.